INNOVAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Innovar, and when can generic versions of Innovar launch?
Innovar is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in INNOVAR is droperidol; fentanyl citrate. There are five drug master file entries for this compound. Additional details are available on the droperidol; fentanyl citrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INNOVAR?
- What are the global sales for INNOVAR?
- What is Average Wholesale Price for INNOVAR?
Summary for INNOVAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 4,093 |
DailyMed Link: | INNOVAR at DailyMed |
US Patents and Regulatory Information for INNOVAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epic Pharma Llc | INNOVAR | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 016049-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |